Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Presta M, Oreste P, Zoppetti G, Belleri M, Tanghetti E, Leali D, Urbinati C, Bugatti A, Ronca R, Nicoli S, Moroni E, Stabile H, Camozzi M, Hernandez GA, Mitola S, Dell'Era P, Rusnati M, Ribatti D.
Presta M, et al. Among authors: bugatti a.
Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):71-6. doi: 10.1161/01.ATV.0000148863.24445.b4. Epub 2004 Oct 28.
Arterioscler Thromb Vasc Biol. 2005.
PMID: 15514208